1144 related articles for article (PubMed ID: 16041307)
21. Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis.
Pearl-Yafe M; Yolcu ES; Stein J; Kaplan O; Shirwan H; Yaniv I; Askenasy N
Exp Hematol; 2007 Oct; 35(10):1601-12. PubMed ID: 17889725
[TBL] [Abstract][Full Text] [Related]
22. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
23. The effect on the proliferation and apoptosis of alloreactive T cells of cell dose in a murine MHC-mismatched hematopoietic cell transplantation model.
Fujioka T; Taniguchi Y; Masuda T; Nishida S; Ikegame K; Kawakami M; Tsuboi A; Hosen N; Murakami M; Oji Y; Oka Y; Sugiyama H; Kawase I; Ogawa H
Transpl Immunol; 2003; 11(2):187-95. PubMed ID: 12799203
[TBL] [Abstract][Full Text] [Related]
24. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
Anderson LD; Mori S; Mann S; Savary CA; Mullen CA
Cancer Res; 2000 Oct; 60(20):5797-802. PubMed ID: 11059776
[TBL] [Abstract][Full Text] [Related]
25. Tolerance to host minor histocompatibility antigens after allogenic bone marrow transplantation. Specific donor-host unresponsiveness is maintained by peripheral tolerizing cells.
Brochu S; Roy DC; Perreault C
J Immunol; 1992 Nov; 149(10):3135-41. PubMed ID: 1431092
[TBL] [Abstract][Full Text] [Related]
26. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
27. Alloantigen recognition is critical for CD8 T cell-mediated graft anti-tumor activity against murine BCL1 lymphoma after myeloablative bone marrow transplantation.
Pillai A; Teo P; George T; Mukhopadhyay A; Dejbakhsh-Jones S; Strober S
Bone Marrow Transplant; 2007 Sep; 40(5):487-97. PubMed ID: 17603512
[TBL] [Abstract][Full Text] [Related]
28. Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk.
Hsieh MH; Varadi G; Flomenberg N; Korngold R
Biol Blood Marrow Transplant; 2002; 8(6):303-15. PubMed ID: 12108916
[TBL] [Abstract][Full Text] [Related]
29. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
30. Virus clearance and immunopathology by CD8(+) T cells during infection with respiratory syncytial virus are mediated by IFN-gamma.
Ostler T; Davidson W; Ehl S
Eur J Immunol; 2002 Aug; 32(8):2117-23. PubMed ID: 12209623
[TBL] [Abstract][Full Text] [Related]
31. Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura.
Zhang F; Chu X; Wang L; Zhu Y; Li L; Ma D; Peng J; Hou M
Eur J Haematol; 2006 May; 76(5):427-31. PubMed ID: 16480433
[TBL] [Abstract][Full Text] [Related]
32. Potential role of host effector memory CD8+ T cells in marrow rejection after mixed chimerism induction in cynomolgus monkeys.
Setoguchi K; Kishimoto H; Kobayashi S; Shimmura H; Ishida H; Toki D; Suzuki T; Ohnuki K; Tate Y; Fujioka S; Abe R; Tanabe K
Transpl Immunol; 2010 Aug; 23(4):194-203. PubMed ID: 20624462
[TBL] [Abstract][Full Text] [Related]
33. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
Chen BG; Liu Z; Wu Y
Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
[TBL] [Abstract][Full Text] [Related]
34. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.
Zelinskyy G; Balkow S; Schimmer S; Schepers K; Simon MM; Dittmer U
Virology; 2004 Dec; 330(2):365-74. PubMed ID: 15567431
[TBL] [Abstract][Full Text] [Related]
35. Critical roles of memory T cells and antidonor immunoglobulin in rejection of allogeneic bone marrow cells in sensitized recipient mice.
Nagata S; Okano S; Yonemitsu Y; Nakagawa K; Tomita Y; Yoshikai Y; Shimada M; Maehara Y; Sueishi K
Transplantation; 2006 Sep; 82(5):689-98. PubMed ID: 16969294
[TBL] [Abstract][Full Text] [Related]
36. A critical role for granzyme B, in addition to perforin and TNFalpha, in alloreactive CTL-induced mouse pancreatic beta cell death.
Sutton VR; Estella E; Li C; Chen M; Thomas HE; Kay TW; Trapani JA
Transplantation; 2006 Jan; 81(2):146-54. PubMed ID: 16436955
[TBL] [Abstract][Full Text] [Related]
37. Fas ligand enhances hematopoietic cell engraftment through abrogation of alloimmune responses and nonimmunogenic interactions.
Pearl-Yafe M; Yolcu ES; Stein J; Kaplan O; Yaniv I; Shirwan H; Askenasy N
Stem Cells; 2007 Jun; 25(6):1448-55. PubMed ID: 17363551
[TBL] [Abstract][Full Text] [Related]
38. Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation.
Mathew JM; Garcia-Morales RO; Carreno M; Jin Y; Fuller L; Blomberg B; Cirocco R; Burke GW; Ciancio G; Ricordi C; Esquenazi V; Tzakis AG; Miller J
Transpl Immunol; 2003; 11(3-4):307-21. PubMed ID: 12967784
[TBL] [Abstract][Full Text] [Related]
39. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
Zorn E; Wang KS; Hochberg EP; Canning C; Alyea EP; Soiffer RJ; Ritz J
Clin Cancer Res; 2002 Jul; 8(7):2052-60. PubMed ID: 12114403
[TBL] [Abstract][Full Text] [Related]
40. Survival and function of MiHA epitope-specific host CD8 TM cells following ablative conditioning and HCT.
Shatry AM; Roopenian DC; Levy RB
Biol Blood Marrow Transplant; 2007 Mar; 13(3):293-8. PubMed ID: 17317582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
